Atrinsic (NASDAQ:PTIX) Stock Falls 5.1% – Here’s Why

Atrinsic Inc. (NASDAQ:PTIX – Get Free Report)’s share price traded down 5.1% during trading on Wednesday. The company traded as low as $0.86 and last traded at $0.86. Approximately 2,428 shares changed hands during mid-day trading, a decline of 92% from the average daily volume of 29,273 shares. The stock had previously closed at $0.9060.

Atrinsic Price Performance

The company has a fifty day moving average of $0.60 and a 200 day moving average of $0.56. The firm has a market capitalization of $1.40 million, a P/E ratio of -0.10 and a beta of 1.82.

Atrinsic Company Profile

(Get Free Report)

Atrinsic, Inc was an internet marketing and digital media company that developed and operated online consumer brands and provided performance-based marketing services. Its activities included customer acquisition, advertising, lead generation and the distribution of digital content and services through online channels.

The company underwent a strategic transformation and later changed its name to Protagenic Therapeutics, Inc As part of that transition, its business focus shifted away from internet marketing toward biotechnology and the development of peptide-based therapeutics.

See Also

Receive News & Ratings for Atrinsic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrinsic and related companies with MarketBeat.com's FREE daily email newsletter.